Standout Papers

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis 2013 2026 2017 2021 2.0k
  1. Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis (2013)
    Brian G. Feagan, Paul Rutgeerts et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 6 from Science/Nature 88 standout
Sub-graph 1 of 14

Citing Papers

Navigating the complexities of drug development for inflammatory bowel disease
2024 Standout
Upadacitinib Induction and Maintenance Therapy for Crohn’s Disease
2023 Standout
60 intermediate papers

Works of Jeffrey Axler being referenced

OP011. Budesonide MMX(R) 9 mg for Inducing Remission in Patients with Mild-to-Moderate Ulcerative Colitis Not Adequately Controlled with Oral 5-ASAs
2015
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
and 4 more

Author Peers

Author Last Decade Papers Cites
Jeffrey Axler 1468 1840 217 681 16 2.4k
Brihad Abhyankar 1365 1684 158 571 37 2.1k
Bruce Salzberg 1600 2134 220 820 39 2.8k
Jean Yves Mary 1099 1289 171 494 26 2.4k
Marcus Harbord 1555 2166 178 626 26 3.0k
Fabian Schnitzler 1749 2295 234 886 42 2.9k
Jean Frédéric Colombel 1214 1551 175 326 14 2.2k
Stephan Targan 1510 2068 201 699 45 3.0k
M. Vilien 1062 1207 213 316 33 1.8k
S. B. Hanauer 1537 2066 166 790 40 3.1k
Kezhen L. Tang 2135 2678 251 831 18 4.9k

All Works

Loading papers...

Rankless by CCL
2026